Playing with opening and closing of heterocycles: using the cusmano-ruccia reaction to develop a novel class of oxadiazolothiazinones, active as calcium channel modulators and P-glycoprotein inhibitors

Molecules. 2014 Oct 14;19(10):16543-72. doi: 10.3390/molecules191016543.

Abstract

As a result of the ring-into-ring conversion of nitrosoimidazole derivatives, we obtained a molecular scaffold that, when properly decorated, is able to decrease inotropy by blocking L-type calcium channels. Previously, we used this scaffold to develop a quantitative structure-activity relationship (QSAR) model, and we used the most potent oxadiazolothiazinone as a template for ligand-based virtual screening. Here, we enlarge the diversity of chemical decorations, present the synthesis and in vitro data for 11 new derivatives, and develop a new 3D-QSAR model with recent in silico techniques. We observed a key role played by the oxadiazolone moiety: given the presence of positively charged calcium ions in the transmembrane channel protein, we hypothesize the formation of a ternary complex between the oxadiazolothiazinone, the Ca2+ ion and the protein. We have supported this hypothesis by means of pharmacophore generation and through the docking of the pharmacophore into a homology model of the protein. We also studied with docking experiments the interaction with a homology model of P-glycoprotein, which is inhibited by this series of molecules, and provided further evidence toward the relevance of this scaffold in biological interactions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B / antagonists & inhibitors
  • ATP Binding Cassette Transporter, Subfamily B / chemistry*
  • Animals
  • Calcium Channel Blockers / chemical synthesis
  • Calcium Channel Blockers / pharmacology
  • Guinea Pigs
  • Heart Atria / drug effects
  • Heterocyclic Compounds / chemistry*
  • Molecular Docking Simulation
  • Muscle, Smooth / drug effects
  • Oxadiazoles / chemical synthesis*
  • Oxadiazoles / pharmacology*
  • Quantitative Structure-Activity Relationship
  • Structural Homology, Protein

Substances

  • ATP Binding Cassette Transporter, Subfamily B
  • Calcium Channel Blockers
  • Heterocyclic Compounds
  • Oxadiazoles